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Introduction {#sec1}
============

Adult stem cell niches provide complex regulatory architectures that maintain the stem cell population and prevent terminal differentiation ([@bib17], [@bib23], [@bib37], [@bib69], [@bib98]). In the adult mammalian brain, the neural stem cell (NSC) niches are unique in supporting neurogenesis ([@bib13], [@bib83]), as only gliogenesis takes place in the remainder of the brain (see e.g., [@bib39], [@bib60]). The brain parenchyma outside these niches (e.g., neocortex; [Figure 1](#fig1){ref-type="fig"}A) even limits the neurogenic potential of transplanted NSCs or neuroblasts ([@bib3], [@bib101], [@bib26], [@bib30], [@bib87]). The largest NSC niche, the sub-ependymal zone (SEZ), generates neuroblasts that migrate to the distant olfactory bulb (OB), where they differentiate and integrate ([Figures 1](#fig1){ref-type="fig"}B and 1C) ([@bib60]). This spatial separation allows the determination of the composition of the NSC niche (SEZ) that maintains the stem cells and generation of neuroblasts in comparison to the OB niche as an environment fostering neuronal differentiation and integration of new neurons.Figure 1High-Resolution Proteome of the Somatosensory Cortex and Neurogenic Niches(A--C) The schematic drawing indicates a sagittal section of the adult murine brain with example photomicrographs of the regions used in this analysis---the non-neurogenic somatosensory cortex (A), the olfactory bulb (OB), where new neurons (labeled for doublecortin \[Dcx\]) integrate (B), and the lateral sub-ependymal zone (SEZ) where most NSCs reside, whereas only a few are located in the medial sub-ependymal zone (MEZ) (C). Sections were immunostained as indicated in the panels and are confocal z stacks.(D) Experimental workflow using loss-less nano-fractionation for library-matched single shot measurements.(E) Schematic of the high-precision cryo-dissection of the SEZ and the MEZ.(F) Picture of a 50-μm frozen coronal section (white, ventral down) with cortex, corpus callosum, and choroid plexus removed. (F′) shows magnification of the dissected region visible as a thin gray line.(G) Photomicrographs of cryo-dissected SEZ and MEZ (separated from striatum \[Str\] and septum \[Sep\]) stained for GFAP and DAPI (left panel) and cryo-dissected SEZ stained for GFAP, collagen 4 (Col4), myelin-associated glycoprotein (MAG), and DAPI (right panel).(H) Number of proteins quantified in the library sample measurements and the library-matched single shot (LMSS) sample measurements for each region. Data are shown as mean ± standard deviation (n = 1 library sample per region, n = 4 single shot samples per region). See also [Figures S1A--S1](#mmc1){ref-type="supplementary-material"}D.(I) Principal component analysis (PCA) for each brain region. Components 1 and 2 separate the main regions. The SEZ and the MEZ are similar in these components.(J) Colors indicate three categories that are enriched, respectively, in the Cx, the OB, and both the SEZ and the MEZ (FDR is presented for each category).(K) Heatmap of 4,786 proteins found to be of different abundance comparing the four brain regions (n = 4 per region). Intensities are based on label-free quantification (LFQ) intensities after unsupervised hierarchical clustering (ANOVA with Benjamin-Hochberg post hoc test, FDR = 0.05).(L) The datasets were annotated with Uniprot keywords and the matrisome annotation (see [STAR Methods](#sec4){ref-type="sec"}). Enriched features of the OB in comparison to the Cx were then scored (0 to 1) and are displayed in a bar graph (1D-annotation enrichment, FDR = 0.05). Conversely, features with a negative score (0 to −1) are enriched in the Cx compared to the OB.(M) Enriched features of the SEZ in comparison to the Cx were analyzed in the same manner (1D-annotation enrichment, FDR = 0.05).Scale bars as indicated in the panels.

The SEZ, located at the lateral wall of the lateral ventricles that are lined by ependymal cells, harbors nestin+ quiescent NSCs that can be activated and give rise to transit-amplifying progenitors (TAPs) that then generate doublecortin (Dcx)-positive neuroblasts ([Figure 1](#fig1){ref-type="fig"}C). The medial side of the lateral ventricle, the medial sub-ependymal zone (MEZ), also shares ependymal cell lining and access to the cerebrospinal fluid (CSF). As it contains many fewer NSCs and Dcx+ neuroblasts ([Figure 1](#fig1){ref-type="fig"}C) than the SEZ, this region provides a useful comparative tissue to identify specific components of the NSC and neurogenesis-associated environment. Individual proteins and ECM structures ([@bib47]) have been described as specific for the NSC niches in the adult murine brain, such as the ECM proteins Tenascin-C (Tnc) and Thrombospondin 4 (Thbs4) that both may regulate aspects of migration ([@bib27], [@bib33], [@bib36], [@bib46]) or the matrix-associated protein Plexin-b2 that regulates proliferation and migration ([@bib85]). However, no comprehensive proteomic analysis of this important niche has yet been performed. Likewise, in the OB, two matrix proteins, Reelin (Reln) and Tenascin-R (Tnr), have been reported to regulate the change from tangential to radial neuroblast migration ([Figure 1](#fig1){ref-type="fig"}B) ([@bib18], [@bib40]), and, besides neuronal activity, little is known about factors allowing the integration of new neurons into pre-existing networks in the adult brain ([@bib41], [@bib61]).

In contrast to the above-described niches, the mature brain parenchyma allows neither neurogenesis nor integration of new neurons in the absence of injury ([@bib32]). It contains a specialized extracellular matrix called "perineuronal nets" (PNNs) that is built up around neurons late in development and serves to restrict neuronal plasticity ([@bib20]). As the NSC niche contains no neurons, and hence no PNNs, its ECM composition is expected to differ from the brain parenchyma, but the actual composition is largely unknown, as are potential differences in ECM composition between the OB and brain parenchyma.

The ECM, the "matrisome," consists of core ECM proteins often forming ECM structures, such as the basement membrane (BM) and associated ECM proteins, many with primarily protein-regulatory functions. The latter is essential for the enrichment and function of many growth factors and other signaling factors and, hence, is of key interest to mediate regulatory functions of a local niche. The proteins associated with the structural ECM can be enriched through detergent de-cellularization ([@bib73]), but this has not yet been done in the NSC niches.

In contrast to the paucity of proteome data, the transcriptomes of SEZ NSCs, their progeny, and the surrounding niche cells are well studied ([@bib4], [@bib12], [@bib45], [@bib62]). However, gene expression analysis has proven inadequate to fully describe the proteome, including the tissue matrix environment ([@bib2], [@bib86]). For example, neurogenic and neuronal mRNAs are upregulated in NSCs and progenitors, but translation is inhibited to avoid premature differentiation and allow amplification of the lineage, a phenomenon referred to as "lineage priming" ([@bib105], [@bib4], [@bib39], [@bib57]). Moreover, proteins may be derived from the CSF that is contributing to the maintenance of the SEZ stem cell niche ([@bib57], [@bib88]). Determining the composition of the proteome, including the matrisome of the neurogenic niches, is thus important, particularly given the influence of the ECM composition on mechanical tissue properties, which regulate fate decisions of adult stem cells, such as muscle or mesenchymal SCs ([@bib25], [@bib35], [@bib98]). Neural crest SCs have been found to differentiate into smooth muscle cells on stiffer substrates and glial cells on softer substrates ([@bib104]), consistent with CNS tissue belonging to the softest tissues in our body ([@bib31]). This softness of CNS tissue is most likely due to low expression of certain structural matrix constituents, such as collagen I, and the soft nuclear matrix of neurons, given their low content of lamin A ([@bib92]). Tissue stiffness has been shown to potently influence neurite outgrowth ([@bib51], [@bib90]), and NSCs possess mechanosensitive ion channels whose activity affects their self-renewal and differentiation ([@bib78], [@bib79]). However, the mechanical properties of the adult stem cell niche are currently unknown.

Here we set out to provide a first in-depth characterization of what makes the composition and architecture of the adult brain's neurogenic niche uniquely different from the non-neurogenic brain parenchyma.

Results {#sec2}
=======

High-Resolution Proteome Defines Niche-Specific Features {#sec2.1}
--------------------------------------------------------

For ultra-deep proteomic assessment of the neurogenic niches, we used library-matched single shot (LMSS) proteomics (see [STAR Methods](#sec4){ref-type="sec"}). Cerebral cortex (Cx) gray matter (GM, omitting the white matter \[WM\] and meninges) was compared with the OB (also omitting the meninges), the SEZ, and the MEZ ([Figure 1](#fig1){ref-type="fig"}D). To obtain SEZ and MEZ samples, we performed cryo-micro-dissections on 100-μm-thick tissue sections after removing cortex with corpus callosum and choroid plexus (10 sections per sample) ([Figures 1](#fig1){ref-type="fig"}E, 1F, and 1F′). The combination of methods allowed very high precision and proteome-measurement depth of the small SEZ and MEZ regions, avoiding the myelin-associated-glycoprotein-rich (MAG+) brain parenchyma ([Figure 1](#fig1){ref-type="fig"}G).

We identified a total of 10,923 proteins in the library samples (four pooled tissue samples from each region) and 6,690 in LMSS samples (n = 4 per region) ([Figure 1](#fig1){ref-type="fig"}H; [Table S1](#mmc2){ref-type="supplementary-material"}). Among the library-exclusive proteins, transcription factors (p = 1.68 × 10^−6^), cytokines, and neurogenesis-associated mitogens (e.g., interleukin-18, insulin growth factor, Vegf-α, etc.) were significantly enriched. As these are low-abundance proteins, *in vivo* proteome measurements of such factors have previously been unattainable. Our library measurements demonstrate that the mitogens and transcription factors known to be required for neurogenesis (e.g., Pax6) ([@bib75]) can be revealed and quantified *in vivo* with a proteome depth of 10,000 proteins ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1D; [Table S1](#mmc2){ref-type="supplementary-material"}).

The principal component analysis (PCA) of the four regions revealed that the SEZ and the MEZ have a more similar proteome than the other two regions ([Figure 1](#fig1){ref-type="fig"}I). An enriched common category was cilium movement (p = 3.93 × 10^−6^) ([Figure 1](#fig1){ref-type="fig"}J), highlighting that proteins from a single cell layer, the ependymal cells lining the ventricle, can be detected: e.g., Tektin (Tek1), a protein exclusive to ependymal cells and NSCs at the SEZ (<https://shiny.mdc-berlin.de/SVZapp/>).

In total, 4,786 proteins had a differential abundance among the four regions (ANOVA, FDR = 0.05) ([Figure 1](#fig1){ref-type="fig"}K). To identify features enriched in the neurogenic niche, we analyzed differences in protein abundance for either the OB or the SEZ in comparison to the Cx. Proteins were annotated with Uniprot keywords and the improved ECM annotation (<http://matrisome.org>; see [STAR Methods](#sec4){ref-type="sec"}). Enriched features of the OB included several nuclear and gene-regulatory processes (1D-annotation enrichment, FDR = 0.05) ([Figures 1](#fig1){ref-type="fig"}L and [S1](#mmc1){ref-type="supplementary-material"}F; [Table S2](#mmc3){ref-type="supplementary-material"}). This suggested that the OB has a larger proportion of gene-regulatory proteins, possibly because of the large population of maturing neuroblasts. Processes less pronounced in the OB compared to the Cx included synapse-associated features and core-matrisome proteins.

Proteins enriched in the SEZ, like in the OB, were associated with gene regulation and also oxidative phosphorylation ([Figures 1](#fig1){ref-type="fig"}M and [S1](#mmc1){ref-type="supplementary-material"}E; [Table S2](#mmc3){ref-type="supplementary-material"}), which is consistent with the fact that NSCs are largely glycolytic and the metabolism has to change as they differentiate into neuroblasts ([@bib5], [@bib48]). Annexin-family proteins were found enriched in the SEZ compared to the Cx ([Figure 1](#fig1){ref-type="fig"}M), a notable observation given their importance in regulating the proliferation and migration of cancer cells ([@bib55]). Core matrisome proteins demonstrated the highest abundance in Cx (p ≤ 0.0001, Kruskal-Wallis test with Dunn's multiple comparison test) ([Figure 2](#fig2){ref-type="fig"}A), and several proteins of the PNNs had higher abundance in the Cx and the MEZ compared to the SEZ and the OB ([Figures 1](#fig1){ref-type="fig"}L and 1M). None of the proteoglycans associated with migration during developmental neurogenesis, such as neurocan, aggrecan, or versican ([@bib64], [@bib65]), were an enriched component of the matrisome at the SEZ; instead, aggrecan was enriched in the OB in line with an association to neuroblasts ([Figures 2](#fig2){ref-type="fig"}B, 2C, and [S2](#mmc1){ref-type="supplementary-material"}A--S2C). These data validate the quality of the dataset and provide a rich resource that can be accessed as a web-based database (<https://neuronicheproteome.org>).Figure 2Niche-Specific ECM and NSC Markers(A) Distribution plots of each brain region in the different categories of the matrisome as indicated. Average LFQ intensities for each protein were *Z* scored and displayed in whisker plots (ANOVA, Kruskal-Wallis test with Dunn's multiple comparison test, ^∗^p = 0.05, ^∗∗^p = 0.01, and ^∗∗∗^p = 0.001).(B) Scatterplot with the matrisome (black) and matrisome significantly different (FDR ≤ 0.1) comparing the SEZ and the MEZ (red) highlighted.(C) Scatterplot with the relative SEZ and OB values and significant differences (FDR ≤ 0.1) between intensities for the SEZ and the OB. Both plots highlight S100a6 and C1ql3 as enriched in the SEZ. See also [Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C.(D--H) Photomicrographs of the ventricle and the SEZ and the MEZ from coronal brain sections of C57BL/6J mouse or mVenus/*C1ql3* transcriptional reporter mouse immunostained as indicated. Note that S100a6 and C1ql3 are not found in Dcx+ neuroblasts or parenchymal astrocytes and, typically, neither in ependymal cells. Scale bars as indicated, and (D) and (E) are z stacks of confocal images, while (F)--(H) are single optical sections. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}A--S4I.(I) *In situ* hybridization shows mRNA expression in the SEZ. Image credit: Allen Institute for Brain Science.

Identification of Niche-Specific Marker Proteins {#sec2.2}
------------------------------------------------

The abundance of neurogenesis-associated proteins was lower in the MEZ compared to the SEZ but still detectable, further supporting the depth of our analysis. One such protein is Tnc, the neurogenic niche-associated ECM protein discussed above ([@bib81]) that was enriched in the SEZ versus the MEZ, as expected ([Figures 2](#fig2){ref-type="fig"}A and 2B). We then compared the relative abundance of proteins in the SEZ, the MEZ, and the OB to the Cx as a control. These region-specific comparisons determined, S100a6 and C1ql3 among others, to be distinctly enriched among matrisome-associated proteins of the SEZ ([Figures 2](#fig2){ref-type="fig"}B, 2C, [S2](#mmc1){ref-type="supplementary-material"}B, and S2C). We therefore aimed to determine which cells produce these SEZ-enriched proteins. Immunostaining for S100a6 was high in the SEZ and comparably absent in the MEZ ([Figure 2](#fig2){ref-type="fig"}D) and low to absent in astrocytes in the Cx parenchyma ([Figures S3](#mmc1){ref-type="supplementary-material"}G and S3H), in agreement with our analysis. Excitingly, however, S100a6 staining labeled NSCs (slow dividing nestin+ cells in the SEZ; [Figures S3](#mmc1){ref-type="supplementary-material"}B, S3C, and S3F), but not neuroblasts (Dcx+; [Figures 2](#fig2){ref-type="fig"}D, 2G, and [S3](#mmc1){ref-type="supplementary-material"}A--S3C). Likewise, S100a6 staining also extends into the rostral migratory stream (RMS), co-localizing with GFAP+ cells, but not Dcx+ neuroblasts ([Figures S3](#mmc1){ref-type="supplementary-material"}I and S3K). It is worth noting that NSCs, expressing GFAP, have been identified also at these more rostral positions ([@bib1]). Moreover, we also found S100a6+ GFAP+ cells in the WM ([Figures S3](#mmc1){ref-type="supplementary-material"}E and S3J), consistent with the presence of some NSCs there ([@bib60]). Thus, S100a6 not only labels NSCs in the dentate gyrus (DG) ([@bib102]) but more broadly allows distinguishing NSCs from astrocytes, which is important as especially reactive astrocytes and NSCs share most of the so-called "astrocyte markers" ([@bib4], [@bib38]).

Interestingly, single-cell RNA sequencing (scRNA-seq) data from the SEZ ([@bib45]) also showed enrichment of S100a6 specifically in a primed-quiescent subtype of NSCs, qNSC2 ([Figure S6](#mmc1){ref-type="supplementary-material"}A), identifying these cells as the main source for the specific enrichment of S100a6 in the SEZ. Most notably, this proved to be the case for most mRNAs encoding for matrix proteins that are highest in quiescent NSCs, whereas activated NSCs, TAPs, and neuroblasts express very few ECM components ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Thus, NSCs contribute to the composition of their own niche (see also [@bib27]).

Some proteins enriched in the SEZ were also enriched at mRNA levels as seen by *in situ* hybridizations in the Allen Brain Atlas ([Figures 2](#fig2){ref-type="fig"}I and [S4](#mmc1){ref-type="supplementary-material"}J). The systematic comparison of RNA and protein enrichment in the SEZ compared to the Cx and the OB, however, showed profound differences ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C; [Table S5](#mmc6){ref-type="supplementary-material"}). For example, some RNAs were expressed at significantly higher levels in the SEZ compared to the Cx, but the respective proteins were lower abundance or not much different between the SEZ compared to the Cx ([Figure S6](#mmc1){ref-type="supplementary-material"}B; [Table S6](#mmc7){ref-type="supplementary-material"}). This is to be expected from the "lineage priming" as introduced above ([@bib4], [@bib39], [@bib57]) and would lead to "false positives" if relying on RNA data only. Even more misleading could be the class of proteins that we found enriched in the SEZ compared to the Cx, which had lower mRNA levels in SEZ compared to the Cx ([Figure S6](#mmc1){ref-type="supplementary-material"}B). For example, the C1ql3 protein is enriched at protein level in the SEZ, but mRNA is lower in the SEZ compared to the Cx. Moreover, C1ql3 was not detectable among the stem cell stages in the published scRNA-seq data ([Figure S6](#mmc1){ref-type="supplementary-material"}C). This prompted us to examine the source of this protein in the SEZ.

To do so, we took advantage of the *C1ql3*-mVenus reporter mouse line ([@bib67]). With this allele, any cell that expresses *C1ql3* is marked by expression of cytoplasmic mVenus (*not* a fusion protein). In brain, C1ql3 has thus far been identified as a synaptic protein and, accordingly, mVenus+ cells in this reporter line in the brain parenchyma are mostly neurons ([@bib67]). In the SEZ, however, *C1ql3*-mVenus+ cells were Dcx negative, i.e., not neuroblasts but nestin+ and S100a6+ NSCs ([Figures 2](#fig2){ref-type="fig"}E, 2F, [S4](#mmc1){ref-type="supplementary-material"}A--S4C, and S4F). Conversely, we could not detect mVenus+ astrocytes in the brain parenchyma and the OB ([Figures S4](#mmc1){ref-type="supplementary-material"}D, S4E, and S4G--S4I). Ependymal cells located at the ventricle and S100b+ did not contain S100a6 levels above background nor co-localized with *C1ql3-*mVenus ([Figures 2](#fig2){ref-type="fig"}G and 2H). Hence our analysis not only identified two SEZ-enriched NSC proteins whose role may extend beyond being niche-specific marker proteins but also showed a multitude of SEZ enriched proteins that were not detected by RNA analysis ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C).

Biochemical Profiling of the Neurogenic Niche-Specific Matrisome {#sec2.3}
----------------------------------------------------------------

Here we present an overview of the regional distribution of all matrisome proteins with significant abundance differences across conditions ([Figure 3](#fig3){ref-type="fig"}; unsupervised hierarchical clustering, Pearson correlation). The OB and the SEZ are particularly rich in serpins, vitronectin, and Tnc, whereas the SEZ and the MEZ share high levels of annexin and several S100 proteins ([Figure 3](#fig3){ref-type="fig"}). Interestingly, annexin and S100 proteins interact and regulate a variety of processes, including membrane fusion and repair ([@bib44]). These may be of particular relevance in migrating cells present in both of these regions. Additional ECM-associated proteins in both the SEZ and the MEZ included the well-known Thrombospondin 4 (Thbs4) and the ECM cross-linking protein Transglutaminase 2 (Tgm2) that has so far not been described at protein level in the neurogenic niches (see below).Figure 3Regional Matrisome Distribution and Neurogenic Niche-Specific MatrisomeWe compared 158 matrisome proteins and 78 of these had a significantly different distribution in the respective regions, of which the somatosensory cortex was found to be most abundant with extracellular matrix proteins. The heatmap displays unsupervised hierarchical clustering of the matrisome proteins with significantly different abundance when comparing the four brain regions (ANOVA with Benjamin-Hochberg post hoc test, FDR = 0.05). Members of different clusters (indicated by bars on the right of the heatmap) are listed on the further right of the heatmap in colored areas.

Matrisome proteins provide structural support and tether cell-surface proteins or soluble growth factors and thereby regulate their signaling functions. A way of experimentally enriching ECM proteins is to de-cellularize tissue using detergents and analyze the detergent-insoluble ECM components ([@bib73]). However, such a method inherently loses ECM-affiliated proteins that associate with weaker affinity with the ECM. In contrast, methods that use protein-abundance correlation across fractions of protein derived by stepwise centrifugation or differential detergent extraction can be used to assess biochemical properties of proteins, including their association strength with ECM, in a proteome-wide fashion. We therefore used the quantitative detergent solubility profiling (QDSP) method ([@bib86]) and sequentially separated Cx, OB, and SEZ tissue samples into four protein fractions.

Tissue proteins were separated by extraction with increasing stringency using consecutive extraction with four distinct detergent mixtures ([Figure 4](#fig4){ref-type="fig"}A), leading to the identification of 8,308 proteins ([Figure 4](#fig4){ref-type="fig"}B; [Table S3](#mmc4){ref-type="supplementary-material"}). For comparison of protein solubility profiles, their intensities were *Z* scored within each region and relative protein abundance was compared in the four fractions by averaging the profile between regions to permit "brain" solubility profile comparisons for specific categories. As expected, we found "brain" core matrisome proteins, such as collagens and laminins, to be enriched in the fourth fraction and thus more insoluble, whereas matrisome-associated proteins, such as S100 proteins and serpins, were most abundant in the first fraction and thus more soluble (p ≤ 0.0001, Kruskal-Wallis test) ([Figures 4](#fig4){ref-type="fig"}C, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B). Notably, the brain-specific ECM proteins associated with the PNNs ([Figures 4](#fig4){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}G) form a soft structural matrix in the Cx, since they typically enrich in fraction three with much lower abundance in the insoluble fraction four (p = 0.0002, Kruskal-Wallis test). The PNN proteins neurocan (Ncan) and hyaluronan and proteoglycan link protein 1 (Hapln1) were distinctly more soluble in the OB compared to other regions ([Figure S2](#mmc1){ref-type="supplementary-material"}G), an observation possibly related to the integration of new neurons into the network and a high degree of synaptogenesis.Figure 4Compartment Analysis with In-Depth Quantitative Proteomes of the Somatosensory Cortex and the Neurogenic Niches(A) With stepwise de-cellularization we determined insoluble and various diffusible grades of ECM and other cellular compartment-associated proteins.(B) Total number of quantified proteins for all regions (top, black and gray) and proteins quantified in each detergent fraction from each of the three brain regions (bottom, color). Each sample fraction is shown as mean ± standard deviation (n = 4 in each brain region).(C) Solubility profile overview and distribution plot for the proteins in the displayed categories. Abundances were *Z* scored and then averaged for each protein in these categories shown in whisker plots with number of proteins in each category displayed in the graphs. Insoluble proteins distribute more toward fraction four and soluble proteins distribute toward fraction one (significance analyzed with Kruskal-Wallis test with Dunn's multiple comparison test). See also [Figures S2](#mmc1){ref-type="supplementary-material"}G, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B.(D) Heatmap of 1,216 proteins with significantly different solubility among our three regions (FDR ≥ 0.05).(E and F) Significantly enriched features among the more soluble (E) and insoluble (F) proteins in the OB when compared to the Cx using the relative difference of the LFQ intensities in the fourth fraction (1D-annotation enrichment, FDR = 0.05). The dataset was annotated with Uniprot keywords, matrisome, and a custom perineural nets annotation (see [STAR Methods](#sec4){ref-type="sec"}).(G) From the relatively more soluble and insoluble proteins in the OB, we display the quantitative profile of lamins of the nuclear matrix and neurogenesis-associated proteins (two-way ANOVA). Data are presented as mean ± SEM.(H) Matrisome proteins with significantly different solubility profiles comparing the three brain regions (*Z* scored LFQ intensity values, two-way ANOVA, p ≥ 0.05). Rows have undergone unsupervised hierarchical clustering.

Comparing all solubility profiles between the three regions, we found 1,208 proteins to have significantly different profiles (two-way ANOVA, p ≤ 0.05) ([Figure 4](#fig4){ref-type="fig"}D). Unsupervised hierarchical cluster analysis revealed the OB to have many profiles that differ in their solubility from Cx and the SEZ, in particular in the fourth fraction. Since such solubility shifts may contain information concerning protein functions, we assessed the cellular features associated with proteins either more or less soluble (only fourth fraction) in the OB compared to the Cx (1D-annotation analysis, FDR = 0.05). Enriched features among the more insoluble proteins in the OB were associated with gene regulation and cell adhesion, as well as core-matrisome proteins and proteoglycans ([Figure 4](#fig4){ref-type="fig"}F; [Table S4](#mmc5){ref-type="supplementary-material"}). Lamin b1 and Lamin b2 were significantly more insoluble in the OB, suggesting that some or many cells have a nuclear matrix that is more insoluble ([Figure 4](#fig4){ref-type="fig"}G; [Table S4](#mmc5){ref-type="supplementary-material"}). It should be noted that many, but not all, gene regulatory-associated proteins had a more insoluble profile in the OB, highlighting possible differences in nuclear architecture that remain to be explored. Along these lines, we observed that the presence of transcriptional and epigenetic regulators in different solubility fractions with tissue specificity, e.g., Sp8 and Dnmt3a, were less soluble, whereas Stat3, Meis2, and Gsk3b were more soluble in SEZ tissue ([Figure 4](#fig4){ref-type="fig"}G). Meis2 is an important regulator of neurogenesis in the SEZ ([@bib49]), prompting the suggestion that different solubility may reveal tissue-specific differences in transcriptional function. Another category in the more insoluble group of the OB included matrisome proteins, e.g., all three detected glypicans (Gpc1, Gpc4, and Gpc5) ([Figure 4](#fig4){ref-type="fig"}H). Thus, its less soluble ECM and nuclear lamina predict potentially higher tissue stiffness of the OB, a prediction that we tested and confirmed below.

Next, we focused on the solubility profiles of ECM components, providing a heatmap of the "brain" matrisome solubility profiles ([Figure 5](#fig5){ref-type="fig"}A; unsupervised hierarchical clustering, Pearson correlation). This highlights that familiar neurogenic niche ECM proteins are surprisingly soluble ([Figures 5](#fig5){ref-type="fig"}B and 5C). Interestingly, the solubility profile of C1ql3 in the SEZ is distinctly different from the one in the OB and the Cx ([Figure 5](#fig5){ref-type="fig"}D), suggesting its localization in a different more soluble compartment compared to its normal synaptic membrane association. Indeed, matrisome proteins were generally more enriched in the soluble compartments of neurogenic niche-specific ECM-associated proteins (p ≤ 0.0001, Kruskal-Wallis test) in the SEZ (n = 26) or the OB (n = 19) compared to the Cx in the LMSS data (FDR = 0.1) ([Figure 5](#fig5){ref-type="fig"}E). The solubility of proteins enriched in the Cx (n = 40) compared to either the SEZ or the OB (FDR = 0.1) in contrast had either a more membrane-associated or non-diffusible solubility profile. The structural ECM is thus not enriched in the neurogenic niche, including the typical "soft" structural brain ECM, although individual proteins with these properties can be found enriched in both the SEZ and the OB. Reln is uniquely insoluble in the OB ([Figure 5](#fig5){ref-type="fig"}C), whereas Tgm2 is one of the few proteins that was enriched in the SEZ (and the MEZ) that has a largely insoluble profile ([Figure 5](#fig5){ref-type="fig"}A).Figure 5Brain- and Niche-Matrisome Composition(A) The matrisome protein solubility profiles are displayed using unsupervised hierarchical clustering of the detergent solubility profiles derived from averaged *Z* scores from each brain region (the Cx, the OB, and the SEZ).(B--D) Detergent solubility profiles for the SEZ-associated ECM proteins (B) Tenascin-C (Tnc), Thrombospondin-4 (Thbs4), and Plexin-b2 (Plxnb2); the OB-associated proteins (C) Tenascin-R (Tnr), Reelin (Reln), and Pleiotrophin (Ptn); and the two neurogenic niche-specific proteins (D) S100a6 and C1ql3 (p = 0.0948). Data are presented as mean ± SEM.(E) Solubility profiles for Cx-, SEZ-, and OB-enriched matrisome proteins shown in whisker plots (ANOVA, p values in graphs).

Transglutaminase 2 Regulates Adult Neurogenesis {#sec2.4}
-----------------------------------------------

Given the specific enrichment and solubility profile of Tgm2 in both the SEZ and the MEZ ([Figure S5](#mmc1){ref-type="supplementary-material"}D), we determined its cellular origin. Tgm2 immunoreactivity was found in ependymal cells ([Figures 6](#fig6){ref-type="fig"}A and 6B) and NSCs (hGFAP-GFP+; see [@bib4], [@bib12]) that extend an apical process to the ventricle ([Figure 6](#fig6){ref-type="fig"}B), but not in neuroblasts (Dcx+) ([Figure 6](#fig6){ref-type="fig"}C). Consistent with ependymal cells and NSCs containing the highest protein levels, these cells isolated by fluorescence-activated cell sorting ([@bib4], [@bib29]) also had high *Tgm2* mRNA levels, whereas TAPs and neuroblasts contained very low mRNA levels ([Figure 6](#fig6){ref-type="fig"}D). Notably, Tgm2 is the only family member detectable in the SEZ (Tgm1, Tgm3, Tgm5, and Tgm6 were not detectable). The expression of Tgm2 in ependymal cells explains its similar levels in the SEZ and the MEZ ([Figure S5](#mmc1){ref-type="supplementary-material"}D), but its additional presence in NSCs implies possible autocrine or cell-intrinsic effects that we explored next.Figure 6Transglutaminase 2 Promotes Neurogenesis(A) NSCs were identified as hGFAP-GFP+ cells in the SEZ in sagittal sections counterstained with Tgm2 and inserted to the right indicated by the dashed line in the lower magnification picture on the left. Both NSCs and ependymal cells were labeled with Tgm2. LV, lateral ventricle.(B) Whole-mount section of the SEZ showing an hGFAP-GFP+ Tgm2+ apical endfoot between ependymal cells delineated by β-catenin+ junctions.(C) Single-plane confocal picture of the coronal section of the SEZ immunostained for Dcx and Tgm2 showing no double-positive cells.(D) Tgm2 expression analysis by qRT-PCR in cells isolated from the SEZ by fluorescence-activated cell sorting (FACS). NSCs were identified by hGFAP-eGFP+ and the apical membrane marker CD133+, ependymal cells (EP) as hGFAP-GFP-/CD133+ and hGFAP-GFP+, and CD133-, PSA-NCAM-, EGFR- cells as niche astrocytes (NA). Note that NSCs and ependymal cells express high levels of *Tgm2* mRNA. The direct progeny of NSCs, the transit-amplifying progenitors (TAPs), isolated as EGFR+, CD133-, PSA-NCAM-, and neuroblasts, isolated as PSA-NCAM+ also hardly expressed Tgm2. Data are presented as mean ± standard deviation.(E) Primary culture from the SEZ stained as indicated showing that Tgm2+ cells were also GFAP+.(F) Experimental setup for the primary SEZ culture and clonal analysis following Tgm2 inhibition with Z-DON (irreversible Tgm2 inhibitor) or Boc-DON (cell membrane impermeable and irreversible Tgm2 inhibitor).(G) 10-μM Z-DON treatment at 4 h after plating significantly reduced the number of retrovirally labeled cell clusters (clones, i.e., a cluster of cells sharing the cell of origin), whereas 100-μM Boc-DON did not alter the number of clones. Data are presented as mean ± SEM. ^∗^p ≤ 0.05, two-tailed Mann-Whitney test.(H) With Z-DON, but not Boc-DON, the proportion of GFP+ clones containing newly generated neuroblasts (Dcx+) was reduced, whereas the proportion of mixed and glial clones arising from NSCs was conversely increased. Data are presented as mean ± SEM, two-way ANOVA with Bonferroni's multiple comparison test, ^∗∗^p ≤ 0.01 and ^∗^∗∗p ≤ 0.001.(I) Examples of retrovirally labeled (CAG-IRES-GFP) clones composed of neuronal, glial, and mixed cell types stained as indicated. Scale bars as indicated.(J) Primary SEZ cultures were treated with 10-nM siRNAs against Tgm2 and showed a reduced number of neuronal clones compared to the control (scrambled siRNA) (n = 4, Data are presented as mean ± SEM, two-way ANOVA with Bonferroni's multiple comparison test, ^∗^p ≤ 0.05).(K) Countings of DAPI stainings from representative tiles (n = 4, with nine tiles counted in each n).(L) Experimental setup for osmotic pump experiment with two time-points, 4 and 7 days, with continuous intra-ventricular infusion of 100-μM Z-DON in artificial CSF.(M) On the contralateral side of the infusion, we quantified EdU+ cells that were either Dcx+ or Dcx− at the SEZ. After 4 days Z-DON treatment, we found a significant reduction in TAPs (EdU+/Dcx−), whereas proliferating neuroblasts (EdU+/Dcx+) remained similar to control (Data are presented as mean ± SEM. ^∗^p ≤ 0.05, two-tailed t test). This trend continued after 7 days treatment (Data are presented as mean ± SEM. p = 0.0537, two-tailed t test). Confocal image stacks from 6 sections were quantified per brain.

To do so, we used primary SEZ cultures as described before ([@bib14]); cells were cultured without growth factors and in the absence of matrix proteins ([Figure 6](#fig6){ref-type="fig"}F). Often a single GFAP+ NSC is surrounded by the Dcx+ neuroblast progeny ([Figures 6](#fig6){ref-type="fig"}E and 6I) with the former Tgm2+, whereas neuroblasts were negative, consistent with the data shown above ([Figures 6](#fig6){ref-type="fig"}C and 6D). To probe Tgm2 function in this culture system, we used 10 μM of the Tgm2 inhibitor Z-DON. Cells were transduced 2 h after plating with retroviral vectors containing CAG-IRES-GFP at low titer to label few cells and allow detection of the progeny of a single cell as a distinct cluster of cells, i.e., a clone ([@bib77]). Notably, a single dose of Z-DON (at 4 h after plating) drastically reduced the number of clones ([Figure 6](#fig6){ref-type="fig"}G; comprising all clusters of GFP+ cells irrespective of their identity), suggesting a possible role of Tgm2 in promoting proliferation or survival. When we analyzed the composition of the clones, we noted a specific effect of the Tgm2 inhibitor on the clones comprising only neuroblasts (referred to as "neuronal clones" in [Figures 6](#fig6){ref-type="fig"}H and 6I) that are generated by proliferating TAPs or neuroblasts in these cultures ([@bib14]). Conversely, NSC clones (containing one or few GFAP+ cells and Dcx+ neuroblasts, referred to as "mixed" in [Figures 6](#fig6){ref-type="fig"}H and 6I) or clones containing only GFAP+ cells (referred to as "glial" in [Figures 6](#fig6){ref-type="fig"}H and 6I) were favored by Tgm2 inhibition ([Figure 6](#fig6){ref-type="fig"}H).

Tgm2 has multiple modes of action, including intracellular and extracellular functions ([@bib24], [@bib56]), and the above inhibitor blocks all of them. The inhibitor Boc-DON cannot enter the cells and hence specifically blocks extracellular Tgm2 but had no effects in these cultures ([Figures 6](#fig6){ref-type="fig"}G and 6H), suggesting that on this artificial glass substrate with high abundant media volume, extracellular functions of Tgm2 play no roles. Importantly, we confirmed the specific role of Tgm2 using Tgm2 small interfering RNA (siRNA) ([Figure 6](#fig6){ref-type="fig"}J). Notably, the reduced number of neuronal progeny after knockdown of Tgm2 was not due to cell death, as the control and knockdown condition had equal numbers of cells ([Figure 6](#fig6){ref-type="fig"}K).

Since Z-DON was as effective as siRNA *in vitro*, we sought to determine whether it would have a similar effect *in vivo*. Osmotic minipumps loaded with 100 μM Z-DON in artificial CSF were implanted intra-ventricular in mice and inhibitor was administered for either 4 or 7 days. A pulse of EdU (1 h prior perfusion) allowed quantification of proliferating neuroblasts (Dcx+ and EdU+ cells) or TAPs (Dcx− and EdU+ cells) at the SEZ. Interestingly, blocking Tgm2 for 4 days affected mostly the number of TAPs, and this trend was largely maintained after 7 days of administrating Z-DON ([Figure 6](#fig6){ref-type="fig"}M). This phenotype obtained *in vivo* is consistent with reduced clone numbers ([Figure 6](#fig6){ref-type="fig"}G) and effects on pure neuronal clones ([Figures 6](#fig6){ref-type="fig"}H and 6J) *in vitro*, as TAPs almost exclusively generate neuroblasts. Thus, the proteome analysis allowed the identification of Tgm2 in promoting neurogenesis from NSCs.

Higher Tissue Stiffness in Neurogenic Niches {#sec2.5}
--------------------------------------------

The above-described tissue-specific distribution of potentially mechanically important proteins and the susceptibility of adult NSCs to mechanical signals ([@bib78], [@bib79]) prompted us to examine the stiffness of these regions in coronal slices using atomic force microscopy (AFM) ([Figure 7](#fig7){ref-type="fig"}A). The brain parenchymal regions, the cortex (GM) and the striatum, had a similar stiffness ([Figure 7](#fig7){ref-type="fig"}B). Both the SEZ and the MEZ regions were significantly stiffer ([Figure 7](#fig7){ref-type="fig"}B), and the SEZ, the main site of neurogenesis, was significantly stiffer than the MEZ, where few neuroblasts arise ([@bib7]) (p ≤ 0.05, Mann-Whitney, two tailed). These data suggested a close correlation between higher tissue stiffness and more NSCs dedicated to adult neurogenesis. To examine the extent to which the stiffness differences of about 100 Pa are relevant for neurogenesis, we cultured the above-described primary SEZ cells on gels with the stiffness of 100 and 200 Pa. Cells were fixed and stained after 5 days, and no difference in total cell number was observed ([Figures 7](#fig7){ref-type="fig"}E and 7F). However, more than double the number of neuroblasts was detected on the stiffer 200-Pa substrate ([Figures 7](#fig7){ref-type="fig"}G and 7H), even though the outcome of this difference appears to depend on cell density (data not shown). In summary, these data support the concept that neurogenesis is responsive to such differences in stiffness.Figure 7Higher Stiffness of the Neurogenic Niches(A) Schematic drawing of the stiffness measurements on coronal slices (300 μm) with AFM.(B) Stiffness was assessed in the SEZ, the MEZ, the striatum, and the Cx. Both ventricular regions are significantly stiffer than the Cx and the striatum that both have similar tissue stiffness. The SEZ was significantly stiffer than the MEZ. Data shown as whisker plots, ^∗^p = 0.05 and ^∗∗^p = 0.01.(C) Representative tissue heatmap of OB measurements with scale bar as indicated.(D) In the OB, the end of the RMS was less stiff in comparison to the adjacent olfactory tract. The granule cell layer (GCL) was even stiffer still, as well as the internal and external plexiform layer (IPL/EPL) and the glomerular layer (GL). Data shown as whisker plots, Mann-Whitney test (two tailed), ^∗^p = 0.05 and ^∗∗∗^p = 0.001.(E) Experimental setup for the primary SEZ culture plated on hydrogels with 100- or 200-Pa stiffness.(F) Number of DAPI cells was similar at the end of the 5-day experimental period.(G) Representative images of the Dcx+ cells at 5 days after plating.(H) Hydrogels with 200-Pa stiffness significantly increased the percentage of Dcx+ cells in comparison to the same primary SEZ culture on hydrogels with 100 Pa stiffness. Data are presented as mean ± standard deviation. ^∗^p = 0.05, paired t test.

Assessing the OB, we also found an increase in stiffness from the RMS toward the granule cell layer (GCL), which was stiffer throughout the OB parenchyma ([Figures 7](#fig7){ref-type="fig"}C and 7D). Thus, both neurogenic niches were significantly stiffer than the brain parenchyma, suggesting that components of the proteome contribute to regulate these niche-specific mechanical properties, which affects neurogenesis.

Discussion {#sec3}
==========

Here we provide a comprehensive characterization of the neurogenic niche proteome compared to normal brain parenchyma and make the data available on an easy-to-use webpage (<https://neuronicheproteome.org>). Our two proteome datasets (LMSS and QDSP) allowed expanding the set of neurogenic niche-specific proteins and defining their region-specific compartment association. These data are an important complement to the RNA expression data, as RNA and protein enrichment are only partially congruent. This has been described in detail when comparing scRNA-seq and deep proteome data in the aging lung ([@bib2]) and was also apparent in our comparison of RNA and proteome data ([Figure S6](#mmc1){ref-type="supplementary-material"}). The possible mechanisms for this are multiple. RNA stability and RNA-binding proteins may differ between brain regions, and the latter (including microRNAs \[miRNAs\]) may differentially regulate translation, leading to different abundances of newly produced proteins. Conversely, protein degradation may be regulated differently between regions, such that RNA could be enriched, but protein may be fast degraded and hence reduced. Likewise, especially for the matrisome proteins, the secretory pathways leading to their final localization in the ECM could be differentially regulated, causing a discrepancy between the mRNA coding for the protein and its amount in the ECM. Lastly, the location of the SEZ at the ventricle puts NSCs in direct contact with the CSF, and several factors released by the choroid plexus into the CSF have already been identified to regulate adult neurogenesis ([@bib57], [@bib88]), including miRNAs ([@bib57]) or proteins ([@bib88]). In the latter case, we would detect the protein in our proteome analysis, but no RNA would be found, which is the case for many. Interestingly, especially proteins of the matrisome enriched in the SEZ were not enriched at RNA levels ([Figure S7](#mmc1){ref-type="supplementary-material"}A), consistent with data obtained in lung ([@bib2]). Prominent categories of proteins enriched in the OB compared to the cortex, not enriched at RNA level, were related to splicing ([Figure S7](#mmc1){ref-type="supplementary-material"}B). Therefore, this proteome analysis provides an important resource, as proteins play key roles in the function of this unique niche.

Specific Matrisome of the NSC Niche {#sec3.1}
-----------------------------------

Various soluble factors are the most explored cell-extrinsic signals that regulate the adult NSC. Indeed, many matrix-associated proteins are more soluble in the neurogenic niches, and we even found several core-matrix proteins to be more soluble in the neurogenic niches compared to other brain regions and tissues ([Figure S5](#mmc1){ref-type="supplementary-material"}C). This includes Hapln1, Tnc, and Thbs4. In addition to binding other core-matrisome proteins, such as collagens and fibronectin, Tnc interacts with a diverse set of ligands, such as growth factors (e.g., Wnt3a and transforming growth factor β \[Tgf-β\]) and receptors (e.g., Toll-like receptor 4 \[TLR-4\] and Rptpβ) ([@bib19]; [@bib70]). Thbs4 may act as, e.g., a voltage-gated ion-channel blocker or have intracellular functions ([@bib8], [@bib36], [@bib54], [@bib74]). The other niche-specific ECM proteins with a soluble profile include serpins, S100 proteins, and annexins that form a core interaction hub in the SEZ-enriched matrisome ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Soluble ECM proteins such as these may stem from the various cell types in the brain or blood ([@bib34]). However, we found no evidence for a general increase in blood proteins from allegedly leaky vessels ([@bib93]) in the SEZ tissue ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E) but rather expression of these genes (e.g., serpinb6, annexin 1, and annexin 5) by cells in the SEZ ([Figure 2](#fig2){ref-type="fig"}I), mostly qNSCs ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Another interesting protein in this category enriched in both the SEZ and the OB is Kininogen 1 (Kng1). Kng1 is a precursor for bradykinin ([Figures 2](#fig2){ref-type="fig"}B and 2C), which has been found to promote neurogenesis versus gliogenesis *in vitro* ([@bib80]). Interaction analysis of the niche-specific matrix protein in the SEZ highlights annexin-S100 protein interactions and calcium-binding and catalytic activity regulation, whereas in the OB, several serpins have known interactions with other negative regulators of endopeptidase activity ([Figures S7](#mmc1){ref-type="supplementary-material"}C and S7D).

Notably, the SEZ-enriched matrisome unraveled here differs profoundly from the enrichments found recently by RNA-seq of NSC niches in the developing Cx of murine or human samples ([@bib28]). Although RNA and proteome discrepancies may contribute, it is important to note that some of the crucial core matrisome proteins regulating embryonic SVZ expansion and cortex folding are not enriched in the adult NSC niche ([@bib63], [@bib64]). Indeed, many of the SEZ-enriched proteins are upregulated at early postnatal stages when the adult NSC niche forms (F.V., P.S., and M. Götz, unpublished data). Thus, as in many other organs, the niche maintaining adult stem cells differs profoundly from the niche regulating expansion in development.

S100a6 and C1ql3 were both soluble ECM-associated proteins that we found enriched in NSCs of the SEZ. Interestingly, S100a6 also marks NSCs in the DG ([@bib102]) and is hence common to NSCs across regions. S100a6 has extracellular and intracellular functions ([@bib21]); some of the latter are calcium dependent and involved in promoting proliferation in various cancer cells ([@bib58], [@bib59]). This may explain its higher levels in late-stage quiescent NSCs compared to postmitotic parenchymal astrocytes. Moreover, S100a6 may be involved in the signal transduction cascade of flow- or stretch-sensitive channels, such as the epithelial sodium channel that is also absent from non-proliferating astrocytes but present in NSCs and increases the frequency of Ca signals when promoting proliferation ([@bib79]).

In brain, C1ql3 has thus far only been identified as a synapse-associated protein ([@bib10], [@bib67], [@bib68]). Here we found it enriched with a specific solubility profile in the SEZ-niche and identified NSCs as the major source. Thus, C1ql3 also allows the discrimination of NSCs from parenchymal astrocytes, an urgent need given the labeling of NSCs by most astrocyte markers (see also [@bib4]). Notably, C1ql3 is enriched in the SEZ only at the protein level and was hence not identified as a NSC marker in RNA analysis ([Figure S6](#mmc1){ref-type="supplementary-material"}B). C1ql3's differential solubility at the SEZ suggests its localization in a different compartment that is unrelated to its reported synapse function in other brain regions. Outside the brain, extracellular C1ql3 has been reported to control cellular glucose homeostasis ([@bib99]), which makes C1ql3 interesting as a potential regulator of NSC metabolism and perhaps part of the metabolism-enriched machinery we identified in the SEZ ([Figure 1](#fig1){ref-type="fig"}M). In order to further demonstrate the functional relevance of the proteome differences detected in this resource, we showed that the niche-candidate Tgm2 regulates proliferation and neurogenesis *in vitro* and *in vivo*. Tgm2 is a multifunctional enzyme and may regulate neurogenesis by intracellular and extracellular mechanisms *in vivo*. Worth noting is its predominant insoluble profile in the SEZ. Most importantly, it serves to substantiate the relevance of proteins found to be enriched in the SEZ.

Specific Matrisome of the OB, the Niche for Neuronal Integration {#sec3.2}
----------------------------------------------------------------

A key aspect of adult neurogenesis is the integration of the new neurons into pre-existing circuitry. However, the niche conditions allowing this integration in the DG and the OB are not characterized. PNNs in the brain parenchyma have spurred much interest because of their role in plasticity ([@bib89]). Overall, many of the PNN-associated proteins are present at a lower degree in the SEZ and the OB compared to the Cx and the MEZ. In the OB, we found two PNN proteins (Hapln1 and Ncan) to be substantially more soluble than in the Cx and the SEZ, which suggests that these proteins may contribute less to PNNs in the OB compared to the Cx and hence constitute a composition of PNN proteins that may be involved in allowing constant synaptic plasticity in the OB. Indeed, Hapln1 is crucial for the formation of new PNNs and is key in mediating plasticity ([@bib9]). Ncan can act as repellent signal for PSA-NCAM and Epha3 signaling and may be integral to neuroblast migration and circuitry integration ([@bib91]). We could further corroborate the absence of a typical PNN composition in the OB by staining with Wisteria floribunda agglutinin (WFA), a lectin-binding carbohydrate of the PNN, e.g., in the Cx, although it does not mark any nets around neurons of the OB ([Figure S4](#mmc1){ref-type="supplementary-material"}K). The limited matrix association of PNN-associated proteins in the OB and the absence of typical PNNs makes them key candidates for the OB's distinct capacity to permit the integration of new neurons into the pre-existing circuitry.

Unique Stiffness of the Neurogenic Niches {#sec3.3}
-----------------------------------------

An ECM that increases tissue stiffness typically contains insoluble proteins, such as the BM proteins, including collagens and laminins ([@bib92]). Our solubility profiles show that the neuron-associated ECM clearly has a different composition and architecture compared to the insoluble BM proteins, and our data suggest it has very little contribution to tissue stiffness. Conversely, we found more insoluble ECM components that may relate to the increased stiffness of the SEZ, such as Laminin-b2 (Lamb2), Nidogen-1 (Nid1), and Perlecan (Hspg2) in the SEZ compared to the MEZ ([Figure S2](#mmc1){ref-type="supplementary-material"}B), which suggests that the SEZ contains more or larger BM structures. This is in line with previous observations suggesting the specific BM structures in the SEZ, referred to as fractones, as sites for growth-factor accumulation ([@bib47]). Moreover, the higher expression of the ECM cross-linker Tgm2 originating from ependymal cells and NSCs may further contribute to the increased mechanical stiffness of this niche, besides its possible intracellular functions shown here *in vitro*. Transglutaminases have previously been shown to stiffen tissue ([@bib66]), and increased substrate stiffness promotes neurogenesis *in vitro* shown here and previously ([@bib78]).

We found no general enrichment of the insoluble ECM in the OB parenchyma, except for Reln, which suggests unique interconnections here that may be linked to its role in promoting neuroblast chain-migration detachment ([@bib40]). Nevertheless, the OB was the stiffest among the investigated brain regions. The OB is altogether a cell dense region and cell density is known to correlate with tissue stiffness ([@bib50], [@bib95]). However, we also found all lamins of the nuclear matrix to be enriched in the OB, and lamin A correlates with tissue stiffness ([@bib92]) ([Figure S2](#mmc1){ref-type="supplementary-material"}F). The lamins were also more insoluble in the OB, which suggests they may have a different composition or associate to cytoskeletal proteins through proteins such as Nesprin-2 (Syne2), which had similar distinct solubility characteristics in the OB. Nesprin-2 regulates nuclear movement during neurogenesis ([@bib103]) and may hence be involved in neuroblast migration in the OB. Cell migration is also regulated by tissue stiffness, and durotaxis (migration toward stiff substrate) has been described for several stem cells ([@bib11], [@bib97]). Moreover, the nuclear envelope can act as a mechanosensor ([@bib22]), highlighting the importance of nuclear envelope and cytoskeletal interactions. Importantly, stiffness has been found to regulate NSC differentiation *in vitro* ([@bib84]), and we showed here the relevance of the 100-Pa difference measured *in vivo* exerting effects on neurogenesis *in vitro*. Thus, the unique properties of the SEZ niche are functionally relevant. Therefore, the niche-specific proteome described here provides a rich resource for a deeper understanding of the unique properties of this NSC niche in comparison to other adult stem cell niches.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Beta-catenin (1/2000)BD bioscienceCat\# 610153; RRID:[AB_397554](nif-antibody:AB_397554){#intref0030}Collagen 4 (1/100)MilliporeAB756P; RRID:[AB_2276457](nif-antibody:AB_2276457){#interref220}DCX (1/500)MilliporeCat\# AB2253; RRID:[AB_1586992](nif-antibody:AB_1586992){#intref0035}GFAP (rb) (1/500)DAKOCat\# Z0334; RRID:[AB_10013382](nif-antibody:AB_10013382){#interref225}GFAP (ms) (1/500)SigmaCat\# G3893; RRID:[AB_477010](nif-antibody:AB_477010){#interref230}GFAP (goat) (1/500)abcamCat\# ab53554; RRID:[AB_880202](nif-antibody:AB_880202){#intref0040}GFP (1/1000)MilliporeCat\# MAB3580; RRID:[AB_94936](nif-antibody:AB_94936){#intref0045}GFP (1/2000-4000)Aves labCat\# GFP-1020; RRID:[AB_10000240](nif-antibody:AB_10000240){#intref0050}MAG (1/400)MilliporeCat\# MAB1567; RRID:[AB_2137847](nif-antibody:AB_2137847){#intref0055}MAP2 (1/1000)SigmaCat\# M4403; RRID:[AB_477193](nif-antibody:AB_477193){#intref0060}Nestin (1/100)MilliporeCat\# MAB353; RRID:[AB_94911](nif-antibody:AB_94911){#intref0065}NeuN (1/100)MilliporeCat\# MAB377; RRID:[AB_2298772](nif-antibody:AB_2298772){#intref0070}S100a6 (1/500)AbcamCat\# ab181975S100B (ms) 1/500)SigmaCat\# S2532; RRID:[AB_477499](nif-antibody:AB_477499){#intref0075}Tgm2 (1/100)LabvisionCat\# MS-224-B0; RRID:[AB_62201](nif-antibody:AB_62201){#intref0080}WFA (biotin conjugated) (1/500)SigmaCat\# L1516-2MG; RRID:[AB_2620171](nif-antibody:AB_2620171){#interref235}**Secondary antibodies**Alexa Fluor® secondary antibodies (488, 555, 647) (1/1000)ThermoFisher ScientificCat\# A-11001; RRID:[AB_2534069](nif-antibody:AB_2534069){#interref240}555 Alexa Fluor® conjugated streptavidinThermoFisher ScientificCat\# S32355; RRID:[AB_2571525](nif-antibody:AB_2571525){#intref0085}**FACS antibodies**CD133-PE (1/250)eBioscienceCat\# 12-1331-82; RRID:[AB_465849](nif-antibody:AB_465849){#intref0090}EGF--Alexa Fluor 647 (1/300)Molecular ProbesCat\# E-35351Anti-PSA-NCAM-PE (1/250)MiltenyiCat\# 130-093-274; RRID:[AB_1036069](nif-antibody:AB_1036069){#intref0095}Rat IgG1 K isotype control PE (1/250)eBioscienceCat\# 12-4301-81; RRID:[AB_470046](nif-antibody:AB_470046){#intref0100}Mouse IgM-PE antibody (isotype control (1/250))MiltenyiCat\# 130-093-177; RRID:[AB_871723](nif-antibody:AB_871723){#intref0105}**Chemicals, Peptides, Recombinant Proteins and Kits**IGPAL-CA-630SigmaCat\# I8896Phosphatase inhibitorsRocheCat\# 04906837001BenzonaseMerckCat\# 70746-3Protease inhibitors (+EDTA)LifeTechCat\# 78430Sodium deoxycholateSigmaCat\# D6750TCEPSigmaCat\# 6465472-ChloroacetamideSigmaCat\# C0267Ammonium acetateSigmaCat\# V800034Formic acidSigmaCat\# 543804GaudiniumSigmaCat\# G4505Thio-ureaSigmaCat\# T8656SDSSigmaCat\# L4509HEPESSigmaCat\# H3375TrypsinSigmaCat\# T9201HyaluronidaseSigmaCat\# H3884DMEM/F12Life TechnologiesCat\# 21331020B27 SupplementLife TechnologiesCat\# 17504044Poly-D-lysine hydrobromideSigmaCat\# P0899GlutaMaxLife TechnologiesCat\# 35050038Trypsin-EDTA (0.05%)ThermoFisher ScientificCat\# 25300054Poly-L-ornithinSigmaCat\# P4957LamininRocheCat\# 11243217001TSA Tetramethylrhodamine kitPerkinElmerCat\# NEL702001KTAcetonitrileSigmaCat\# 271004Trifluoroacetic acidSigmaCat\# 302031Micro BCA protein assay kitThermoFisher ScientificCat\# 23235Goat SerumThermoFisher ScientificCat\# 16210072RLT lysis bufferQIAGENCat\# 79216Triton X-100SigmaCat\# **T8787**RLT lysis bufferQIAGENCat\# 79216RNeasy Micro KitQIAGENCat\# 74004RNeasy Mini KitQIAGENCat\# 74104SuperScript IIIInvitrogenCat\# 18080093iQ SYBR Green SupermixBIO-RADCat\# 1708880IsoFloAbbott LaboratoriesCat\# NDC 0044-5260-03DMSOSigmaCat\# D2438-10MLZDONZediraCat\# Z006BocDONZediraCat\# B003EdUThermoFisher ScientificCat\# E10187Click-iT EdU Alexa fluor 647 Imaging kitInvitrogenCat\# C10340HiPerFect® transfection reagentQIAGENCat\# 301704Allstars Negative control siRNAQIAGENCat\# 1027280FlexiTube GeneSolution for Tgm2QIAGENCat\# GS21817GlutaraldehydeSigmaCat\# G5882(3-Aminopropyl) trimethoxysilane (APTMS)SigmaCat\# 281775AcrylamideSigmaCat\# A4058N-Hydroxyethyl-acrylamideSigmaCat\# 697931Bis-acrylamideFisher ScientificCat\# BP1404-250**Experimental Models: Organisms/Strains**C57Bl6/J miceIn-house breedingN/A*C1ql3*^*flox*^; C1ql3^tm1.1Sud^[@bib67]RRID: MGI_5779515hGFAP-GFP mice (Tg(GFAP-EGFP)1Hket)[@bib76]MGI:[6188855](mgi:6188855){#intref0110}**Deposited Data**Proteome datasetProteomeXchange Consortium at <http://proteomecentral.proteomexchange.org>PXD016632Supplementary tables (of in-article analyzed data)The journalN/AProteome dataset<https://neuronicheproteome.org>N/AMicroarray datasetGene Expression Omnibus at <https://www.ncbi.nlm.nih.gov/geo/>accession number [GPL15692](ncbi-geo:GPL15692){#intref0130}**Software and Algorithms**MATLAB, including custom-written scripts to analyze AFM dataMathworks: <https://www.mathworks.com/products/matlab/Custom> MATLAB scripts: <https://github.com/FranzeLab>Version R2018bMaxquant<http://www.coxdocs.org/doku.php?id=maxquant:start>Version 1.6.0.16Perseus<http://www.coxdocs.org/doku.php?id=perseus:start>Version 1.6.0.7PrismGraphpadVersion 5Microarray analysisGeneSpring GX v11.5.1 software packageAgilent TechnologiesString<https://string-db.org/>N/AZEN imaging softwareCarl ZeissN/A**Other**CellHesion 200 AFM headJPK InstrumentsN/APetriDishHeater for maintaining constant temperature during AFM-based stiffness measurementsJPK InstrumentsN/ATipless silicon cantilevers for AFM-based stiffness measurementsNanoWorldArrow TL-1Spherical probes for AFM cantileversmicroParticles GMBH37.28 μm polystyrene beads, PS-R-37.0

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Prof. Magdalena Götz (<magdalena.goetz@helmholtz-muenchen.de>). This study did not generate new unique reagents.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### WT Mice (Proteomics, Cell Culture, Osmotic Pumps, IHC, and AFM) and hGFAP-eGFP mice (FACS, IHC) {#sec4.3.1}

All experimental procedures in this study done at LMU Muenchen were performed in accordance with German and European Union guidelines and were approved by the government of upper Bavaria. In addition, all procedures performed in Cambridge were carried out in accordance with the UK Animals (Scientific Procedures) Act 1986 and with university guidelines. For the proteomics experiments, only male C57BL/6J mice between 8-10 weeks were used, for osmotic pump experiments, only male C57Bl6/J mice between 10-12 weeks were used, and for AFM experiments, only male C57Bl6/J mice aged 8 weeks were used (to reduce any potential variability). For other experiments both male and female C57BL/6J mice were used between 8-12 weeks. For FACS and IHC experiments, we used both male and female 8-12 week old hGFAP-eGFP mice (Tg(GFAP-EGFP)1Hket, [@bib76]). Mice were fed *ad libitum* and housed with a 12/12 h light and dark cycle and kept under specific-pathogen-free (SPF) conditions.

### C1ql3 Reporter Mice {#sec4.3.2}

The analysis of *C1ql3* gene expression was performed using the IRES-mVenus knockin reporter allele (*C1ql3*^*flox*^; C1ql3^tm1.1Sud^ RRID: MGI_5779515) described in ([@bib67]). The background strain of the mice was C57BL/6. All procedures involving the use of mice at the University of Connecticut Health Center were approved by the Institutional Animal Care and Use Committee, and in accordance with guidelines set forth by the National Research Council of the National Academies Guide for the Care and Use of Laboratory Animals.

### Primary SEZ Culture {#sec4.3.3}

The sub-ependymal zones (SEZ) of 8 - 12 weeks old C57BL/6J wild-type mice were dissected in Hank's Balanced Salt Solution (HBSS) with 10 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and after removing the dissection medium incubated in 5 mL dissociation solution (HBSS containing 15 mM HEPES, 5.4 Glucose, 3.4 mg trypsin powder and 3.5 mg hyaluronidase powder) at 37°C for 15 min. The SEZ pieces were triturated 10 times using a 5 mL glass pipette and incubated for another 15 min at 37°C. 5 mL ice-cold solution 3 (solution 3: EBSS (Earle's Balanced Salt Solution) containing 20 mM HEPES and 0,04 g/mL BSA (Bovine Serum Albumin); pH 7.5) were added and solutions were mixed by pipetting 10 times with a 10 mL pipette. The cell suspension was filtrated through a 70-μm cell strainer and centrifuged at 250 g for 5 min at 4°C. The supernatant was discarded and cells were resuspended in 10 mL ice-cold solution 2 (solution 2: HBSS containing 0.9 M Sucrose; pH 7.5) and centrifuged at 650 g for 10 min at 4°C. After discarding the supernatant, cells were resuspended in 2 mL ice-cold solution 3. 2 mL of the cell suspension were added to a 15 mL falcon tube with 12 mL ice-cold solution 3 and centrifuged at 350 g for 7 min at 4°C. The supernatant was carefully removed and cells were resuspended in B27-supplemented culture medium (culture medium: DMEM/F12 (1:1) with 1x GlutaMAX containing 1x B27 serum-free supplement, 100 units/mL penicillin, 100 mg/mL streptomycin, 8 mM HEPES) and seeded (2 SEZs per well) onto poly-D-lysine - coated (PDL) coverslips in 24-well tissue culture plates ([@bib77]). Cells were kept in the incubator for 7d at 37°C and 5% CO~2~, with the exception of cultures on hydrogels (see Hydroxy-Acrylamid Gel Preparation for Cell Culture) that were kept for 5 d.

Method Details {#sec4.4}
--------------

### Sample Preparation for Proteome Analysis {#sec4.4.1}

Library-Matched Single Shot (LMSS) *M*ethod. Mice were sacrificed by cervical dislocation and brains were subsequently extracted and put into cold phosphate buffered saline (PBS). The ventricular walls were laid bare by removing the dorsal ventricular wall and all tissue above it, as well as the choroid plexus. Brains were then snap-frozen on dry ice and cut into 100 μm sections on a cryostat (Leica CM1000S). The medial (MEZ) and lateral ventricular (SEZ) walls were then manually dissected under a light microscope (Leica MZ6). 8-10 sections from each animal were collected per sample (n = 8) and kept on dry ice until tissue lysis. Somatosensory cortex (Cx) samples were dissected by removing corpus callosum and top layer of cortex (including meninges). Olfactory bulb (OB) was dissected by cutting out the core of the OB approximately along the external plexiform layer. Both Cx and OB samples were subsequently snap-frozen on dry ice (n = 8). Tissues were lysed in buffer containing 0.1 M Tris-HCl (pH 8.5), 1% (w/v) Sodium Deoxycholate, 10 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP), and 40 mM 2-Chloroacetamide at 99°C for 10 min. The lysates were sonicated for 2 × 15 min (or until homogeneous) (Bioruptor, model UCD-200, Diagenode) and protein concentration was determined using the BCA method (Micro BCA protein assay kit) according to manufacturer instructions. 25 μg of protein was digested with LysC and trypsin overnight at 37°C. 250 μl Isopropanol with trifluoroacetic acid (TFA) (each sample contains 1% TFA) was added to each sample and then mixed strongly. Samples were desalted using the StageTip method with SDB-RPS (styrene-divinyl-benzene reverse phase sulfonate; 3M, \#2241) filters ([@bib52]). Therefore, filters were activated with acetonitrile (ACN) and equilibrated with 30% methanol (MeOH) and 1% TFA. After washing with 0.2% TFA, the samples were added to the stage tips and then filters were washed again. Elution was done using 1% Ammonia and 80% ACN. Four of the peptide samples from each region were combined and used for the library proteome of each region. These pooled peptide samples were divided into 8 fractions with nano-fractionation using a high pH reversed-phase fractionator that switches the elution flow every 90 s using a rotating valve ([@bib53]). The four remaining single-shot samples from each region were analyzed without fractionation.

Quantitative Detergent Solubility Profile (QDSP) Method. Mice were sacrificed by cervical dislocation and brains were subsequently extracted and put into cold PBS. The OB was removed by dissection at its base. Somatosensory cortex (Cx) was dissected using a 2.5 mm biopsy punch and the white matter was removed. Both subependymal zones (SEZ and MEZ) were dissected ([@bib77]). All samples were homogenized using a (100 μl) dounce homogenizer (Wheaton \#357844) in 100 μl PBS (with protease inhibitor cocktail and Ethylenediaminetetraacetic acid (EDTA)) and directly frozen in liquid nitrogen and stored at −80°C until tissue protein fractionation. Tissue lysates from 3 animals were pooled, resulting in 5 samples per region and then processed simultaneously (a total of 15 mice). Following centrifugation, we collected the supernatant (protein fraction 0) and then sequentially extracted proteins using the MS analysis adapted de-cellularization protocol of Schiller et al. ([@bib86]). Therefore, we resuspended the pellet in three buffers, each followed by a centrifugation for 20 min at 16,000 g. The samples were incubated in buffer 1 (150 mM NaCl, 50 mM Tris--HCl (pH 7.5), 5% glycerol, 1% IGEPAL, 1 mM MgCl~2~, protease inhibitors (+EDTA), 1% benzonase, 1 × phosphatase inhibitors) and buffer 2 (150 mM NaCl, 50 mM Tris--HCl (pH 7.5), 5% glycerol, 1.0% IGEPAL, 0.5% sodium deoxycholate, 0.1% SDS, 1 × protease inhibitors (+EDTA), and 1% benzonase) for 20 min on ice, and in buffer 3 (500 mM NaCl, 50 mM Tris--HCl (pH 7.5), 5% glycerol, 1.0% IGEPAL, 2% sodium deoxycholate, 1% SDS, 1 × protease inhibitors (+EDTA), and 1% benzonase) for 20 min at RT. Each of the supernatant from the buffer treatment resulted in fraction 1, 2, and 3, with the residual insoluble material resulting in fraction 4. Fraction 0 and 1 were combined to generate our first fraction. All four fractions were precipitated in 80% acetone and sonicated for 5x30 s (Bioruptor, model UCD-200, Diagenode). Afterward, samples were incubated at −20°C for a minimum of 1 h and were then centrifuged. The precipitation was repeated once in order to remove any residual detergent. Alkylation/reduction buffer (100 mM Tris-HCl (pH 8.5), 6M GDmCl, 10 mM TCEP, and 50 mM 2-chloroacetamide) was added to the samples and then boiled at 99°C for 15 min, followed by sonication for 10 × 30 s. Protein concentration was determined using the BCA method (Micro BCA protein assay kit) according to manufacturer instructions. Enzymatic digestion was done in two steps. First, samples were incubated at 37°C for 2 h with LysC (1/50) and then with LysC (1/50) and Trypsin (1/25) overnight. Both digestions were aided by 10 × 30 s sonification. Samples were then acidified by adding 1% TFA followed by desalting using the StageTip method with SDB-RPS filters ([@bib52]). Therefore, filters were activated with acetonitrile (ACN) and equilibrated with 30% methanol (MeOH) and 1% TFA. After washing with 0.2% TFA, the samples were added to the stage tips and then filters were washed again. Each protein lysate was eluted into three peptide fractions using three buffers (buffer 1: 150 mM NH~4~HCO~2~, 40% acetonitrile, 0.5% Formic acid (FA); buffer 2: 150 mM NH~4~HCO~2~, 60% acetonitrile, 0.5% FA and buffer 3: 5% ammonia (from 25% stock solution) and 80% acetonitrile) resulting in a total of 12 fractions per sample.

### Mass Spectrometry {#sec4.4.2}

For both the LMSS (including each library sample) and QDSP samples, we loaded approximately 2 μg of peptides in buffer A (0.1% (v/v) formic acid). We separated peptides by a 2 h gradient in a 50 cm long C18 column (75 μm inner diameter filled in house with ReproSil-Pur C18-AQ 1.9-lm resin (Dr. Maish GmbH)). Samples were eluted in 5%--60% buffer B (0.1% (v/v) formic acid, 80% (v/v) acetonitrile) at a flow rate of 250 nL/ min using a nanoflow UHPLC (Easy nLC, Thermo Fisher Scientific) online coupled to the mass spectrometer (Q Exactive HF Orbitrap, Thermo Fisher Scientific). Each gradient was followed by a wash with buffer B and recalibration with buffer A. Survey scans had a resolution of 70,000 at m/z 400 with a maximum injection time of 20 ms. Target value for the full scan MS spectra was 3 × 10^6^ and isolation window of 1.6 m/z with 10 most abundant precursor ions chosen for fragmentation. MS/MS scans had a resolution of 17,500 at m/z 400 with a maximum injection time of 120 ms. Ion target value for the MS/MS scan was 1 × 10^5^.

### Immunohistochemistry {#sec4.4.3}

Brain Sections. For obtaining brain sections, mice (hGFAP-eGFP, mVenus/*C1ql3*, or C57BL/6J) were anaesthetized by intraperitoneal injection of ketamine (100mg per kg of body weight) and xylazine (10mg per body weight) and then transcardially perfused first with PBS followed by 4% Paraformaldehyde (PFA). Brains were dissected and cut at 80-100 μm thickness at the vibratome (Leica VT1000S) or 30 μm at the cryostat (Leica CM3050S). Sections were stained with primary antibodies in PBS containing 0.1% Triton X-100 and 10% normal goat serum (NGS) overnight at 4°C, washed and incubated with secondary antibodies in PBS containing 10% NGS for 2 h at RT. mVenus/*C1ql3* expression was detected using chicken anti-GFP (Aves, 1:4000).

Perfused brains from the osmotic pump experiments were sectioned coronally (20 μm) along the ventricles. Sections were stained for Dcx and EdU according to manufacturer instructions (Click-iT™). Photomicrographs of the SEZ contralateral to the pump implantation site for quantifications were acquired using confocal microscope LSM 710 (Zeiss).

Whole Mounts. Whole mounts of the SEZ from three months old hGFAP-eGFP transgenic mice were dissected ([@bib71]) and fixed for 15 min with 2% PFA. After washing with PBS, the tissue was stained for 48 h with primary antibodies in PBS containing 0.1% Triton X-100 and 10% normal goat serum (NGS). Whole mounts were washed three times with PBS at room temperature and incubated with the secondary antibodies in PBS containing 10% NGS overnight at 4°C. After three washings in PBS, DAPI was added for 5 min and washed again. Primary antibodies used were: mouse IgG1 anti-Tgm2 (Labvision, 1:100), rabbit anti-β-catenin (Sigma, 1:2000) and chicken anti-GFP (Aves, 1:2000). Tyramide Signal Amplification was used to enhance the Tgm2 fluorescence signal according to the manufacturer instructions (TSA Tetramethylrhodamine kit, PerkinElmer). Photomicrographs were acquired using confocal microscope LSM 710 (Zeiss).

Primary SEZ *C*ultures. Primary SEZ cultures were fixed with 400 μl of 4% (wt/vol) PFA for 15 min at room temperature (RT) and afterward washed twice with PBS. The staining solution contained primary antibodies in PBS with 0.5% Triton X-100 and 10% NGS. Primary antibodies used were: mouse IgG1 anti-Tgm2 (Labvision, 1:100), chicken anti-GFP (Aves, 1:2000), rabbit anti-GFAP (Dako, 1:500), and guinea pig anti-Dcx (Millipore, 1:500). Cells were incubated with the primary antibodies at 4°C overnight, washed with PBS twice and incubated with secondary antibodies in PBS with 10% NGS for 2 h at RT. Photomicrographs were acquired using fluorescent microscope AXIO Imager.Z1 (Zeiss).

All primary and secondary antibodies used can be found in the KEY RESOURCES TABLE (including the used concentration).

### Fluorescence-activated Cell Sorting {#sec4.4.4}

SEZ from heterozygous hGFAP-eGFP ([@bib76]) and C57BL/6J (WT) mice were dissected in dissection medium (HBSS containing 10mM HEPES) on ice and transferred into a 15 mL falcon tube containing 5 mL of solution 1 (solution 1 (HBSS-glucose), see above, 0,81% glucose, 15 mM HEPES in HBSS; pH 7.5). The tissue was mechanically dissociated by pipetting up and down ten times with a fire-polished glass Pasteur pipette. 100 μl of 0.05% trypsin was added to the sample, followed by an incubation step at 37°C for 15 min. Trituration was repeated after 15 min with a fire-polished Pasteur pipette and cells were incubated for additional 15 min. Final trituration was done ten times at the end of the incubation. 5 mL of ice-cold solution 3 (solution 3 (BSA-EBSS-HEPES) 20 mM HEPES, 0.04 g/mL BSA in EBSS; pH 7.5) was added and solutions were mixed by pipetting several times up and down. The cell suspension was filtrated using a 70-μm cell strainer and centrifuged at 180 g for 5 min at 4°C. The supernatant was removed and cells were resuspended in 10 mL of ice-cold solution 2 (solution 2 (saccharose-HBSS) 0.9 M saccharose) in HBSS; pH 7.5) and centrifuged at 510 g for 20 min at 4°C. The pellet was resuspended in 2 mL of ice-cold solution 3 and pured on top of 12 mL of ice-cold solution 3 and centrifuged at 290 g for 12 min at 4°C. Staining solution (0.02% sodium azide, 10%, FBS in PBS) was added to the pellet and cells were incubated with primary antibodies for 30 min at 4°C. After washing with PBS, cells were resuspended in PBS and sorted using the FACS Aria III (BD). Gates were set by the use of isotype controls ([@bib29]).

To collect neural stem cells (NSC), transient amplifying progenitors (TAP), neuroblasts (NB), ependymal cells (EC) and niche astrocytes (NA) we stained the cells as follows: tube 1, cells from hGFAP-eGFP mice with CD133-PE (1:250); tube 2, cells from hGFAP-eGFP mice with CD133-PE (1:250), EGF--Alexa Fluor 647 (1:300) and Anti-PSA-NCAM-PE (1:250) and tube 3, cells from hGFAP-eGFP mice with Anti-PSA-NCAM-PE (1:250). Controls to set the gates were prepared as follows: tube 4, cells from WT mice lacking any antibody; tube 5, cells from WT with rat IgG1 K isotype control PE (1:250); tube 6, cells from WT mice with mouse IgM-PE isotype control (1:250).

### qPCR {#sec4.4.5}

FACS sorted cells were directly collected into RLT lysis buffer (QIAGEN) during the sorting procedure. Total RNA was isolated with the RNeasy MICRO kit (QIAGEN) according to the manufacturer's instructions. Quality and concentration of total RNA was examined with the Agilent Bioanalyzer. Subsequently, cDNA was synthesized with SuperScript III (Invitrogen) as per manufacturer's instructions. qPCR was performed on an Opticon (BIO-RAD) with iQ SYBR Green Supermix (BIO-RAD) and expression levels were normalized to GAPDH.

### Clonal Analysis in Primary SEZ Cultures {#sec4.4.6}

The primary SEZ cultures were prepared for cluster analysis according to the protocol above ([@bib77]). The SEZ from two mice were pooled in order to provide an n = 1 and the cells were plated in two wells (24-well plate) onto poly-D-Lysin coated coverslips. An n = 4 was prepared and analyzed for these experiments. Low titer of CAG-IRES-GFP retrovirus was added at 2 h after plating. Tgm2 inhibitor Z-DON (Zedira) or Boc-DON (Zedira) was added 4 h after plating at a concentration of 10 μM and 100 μM, respectively. Control samples had the equivalent volume of DMSO as the Boc-DON samples added to them (2 μl/well). Cells were incubated at 37°C with 5% CO~2~ for 7 days until fixation with 4% PFA for 15 min at RT. Immunocytochemistry was performed as described above. Cluster counting and analysis was performed after photomicrograph acquisition of the whole coverslips (Axio Imager M2m, Zeiss). SiRNA experiments were performed in the same manner as the *in vitro* inhibitor experiments, except that the siRNA (QIAGEN) was added to the cultures immediately after plating together with an equal part Hitransfect (QIAGEN) (mixed 30 min prior to use). Each well was transfected with a total concentration of 10 nM siRNA containing four Tgm2 siRNAs (Flexitube, QIAGEN) or the same concentration of scrambled siRNA control (Allstar negative control, QIAGEN).

### Hydroxy-Acrylamid Gel Preparation for Cell Culture {#sec4.4.7}

In order to prepare gels with different stiffness we used the method developed by [@bib6]. Glass bottom Petri dishes were washed first with 70% Ethanol and then 0.1% sodium hydroxide (NaOH). The NaOH treated surface was treated with (3-Aminopropyl) trimethoxysilane (APTMS) for 3 min, washed and subsequently 0.5% glutaraldehyde was applied for 30 min. The gel solution was prepared by adding 500 μl 40% acrylamide, 65 μl 100% hydroxyl-acrylamide and 250 μl 2% bis-acrylamide. 89.4% and 88.8% PBS were added to the premix to obtain the desired shear moduli of 100 Pa and 200 Pa, respectively. The desired gel-stiffness was confirmed with Atomic force microscopy (AFM). Finally, gels were coated with Poly-L-ornithin (Sigma, P4957) for 2 h followed by Laminin coating (Roche, \#11243217001) for another 2 h.

### Osmotic Pump Preparation and Surgery {#sec4.4.8}

Osmotic pumps (model 2001, ALZET®) were prepared the day before surgery according to the vendors instructions. Pumps were filled with 100 μM Z-DON in artificial cerebrospinal fluid (aCSF) or DMSO in an equivalent concentration (0.4%) as in the treatment group. Pumps were kept in sterile PBS at 37°C until surgery. The experimental procedure was approved by the government of upper Bavaria. Mice were anaesthetized by intraperitoneal injection of fentanyl (0.05 mg/kg), midazolam (5 mg/kg), and medetomidine (0.5 mg/kg) and after the surgery the anesthesia was antagonized by injection of buprenorphine (0.1 mg/kg), atipamezole (2.5 mg/kg), and flumazenil (0.5 mg/kg). Intra ventricular osmotic pump implantation (Brain kit 2, ALZET®) was performed at the coordinates 1.2 mm laterally to and 0.5 mm posterior to the bregma (right side) ([@bib57]). The experimental endpoints were 4 (n = 3) and 7 days (n = 4) after surgery. 5 mg/mL EdU in saline was administered i.p. at a volume of 10 ul per gram of the mouse's weight 1 h h prior perfusion. The mice were perfused with 4% PFA and the brains were post-fixated overnight.

### Stiffness Measurements {#sec4.4.9}

Sample Preparation. Male C57BL6/J mice (N = 5 animals), aged 8 weeks, were anaesthetized using 5% isofluorane (IsoFlo, Abbott Laboratories) and euthanized by intraperitoneal injection of a lethal dose of pentobarbital (Pentoject, Animalcare UK), followed by cardiac perfusion with cold slicing aCSF. Brains were immediately dissected out into cold slicing aCSF, keeping the olfactory bulbs intact, and sections prepared for stiffness measurements using the *ex vivo* acute CNS slice protocol described previously in [@bib50] and [@bib72]. Hence, each brain was embedded in 4% low melting point agarose (Sigma; in 1 × PBS), the agarose block containing the tissue was glued onto a vibratome platform (Leica), and 300 mm thick coronal sections were cut in cold slicing aCSF. Sections containing the anatomical regions of interest were transferred to a collection chamber containing measuring aCSF at room temperature (approx. 20°C) and allowed to equilibrate for ∼5-10 min. Sections were then attached to 35 mm Petri dishes (TPP) using small dabs of superglue at the outer corners of the surrounding agarose, immediately covered with fresh measuring aCSF, and transferred to the AFM set-up for measurement. The time elapsed between euthanasia of the animals and the beginning of slicing was ∼30 min.

The compositions of the buffers used in this protocol were as follows: for slicing aCSF, 191 mM sucrose, 0.75 mM K-gluconate, 1.25mM KH~2~PO~4~, 26 mM NaHCO~3~, 4mM MgSO~4~, 1mM CaCl~2~, 20 mM glucose, 2 mM kynurenic acid, 1 mM (+)-sodium L-ascorbate, 5 mM ethyl pyruvate, 3 mM myo-inositol, and 2 mM NaOH; and for measuring aCSF, 121 mM NaCl, 3mM KCl, 1.25 mM NaH~2~PO~4~, 25 mM NaHCO~3~, 1.1 mM MgCl~2~, 2.2 mM CaCl~2,~ 15mM glucose, 1mM (+)-sodium L-ascorbate, 5mM ethyl pyruvate, and 3mM myo-inositol. Both solutions were freshly prepared before each experiment and bubbled with 95% O~2~ and 5% CO~2~, beginning at least 30 min before first use and continuing throughout the procedure ([@bib50], [@bib72]).

Atomic Force Microscopy (AFM) Setup. A JPK CellHesion 200 atomic force microscope (JPK Instruments) was mounted on an inverted optical microscope (AxioObserver.A1, Zeiss) with a motorised *x-y* stage (JPK Instruments). For stiffness measurements, the spring constant *k* of tipless silicon cantilevers (Arrow-TL1, NanoWorld) were determined using the thermal noise method ([@bib43]) and cantilevers with *k* of 0.01-0.04 N/m (for olfactory bulb (OB) measurements) or 0.05-0.07 N/m (for SEZ/MEZ measurements) were selected. Spherical monodisperse polystyrene beads (diameter = 37.28 ± 0.34 μm (for olfactory bulb) or 19.3 ± 0.34 μm (for SEZ/MEZ)) (microParticles GmbH) were used as probes and attached to the ends of the cantilevers using heat-curing glue (M-Bond 610, MicroMeasurements). The use of spherical probes ensured a consistent contact area with the sample surface and prevented damage to the slices. A PetriDishHeater (JPK Instruments) was set up on the motorised stage and used to maintain samples at a set temperature of 34°C for the duration of AFM measurements.

AFM Measurements. Prepared sections were placed in the sample holder and allowed to equilibrate for ∼5 min while brightfield images of the slices were collected with an Andor Zyla 4.2 CMOS camera (connected to a modified upright AxioZoom V.16 system (Zeiss)). Force-distance curves (set force: 10 nN, approach speed: 5 μm/s, sampling rate: 1,000 Hz) were either taken manually (for SEZ/MEZ measurements), or automatically every 30-40 μm apart in a raster scan (for OB), using a custom-written script ([@bib50], [@bib51]) generating a 'stiffness map' of the area. For stiffness maps, images of the upper right and lower left corners of the measured area were also collected to identify the region of the slice mapped by the AFM.

### Microarray Analysis {#sec4.4.10}

After dissecting the OB, SEZ and Cx the RNA was extracted using the RNeasy Mini Kit from QIAGEN following the manufacturer's instructions. Sample preparation and microarray analysis was carried out by Arraystar applying the Agilent Array platform. The sample preparation and microarray hybridization were performed based on the manufacturer's standard protocols with minor modifications (Agilent Low Input Quick Amp Labeling Kit). Briefly, the sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3′ bias utilizing a random priming method. The labeled cRNAs were hybridized onto the Mouse LncRNA Array v2.0 (8 × 60K, Arraystar). After having washed the slides, the arrays were scanned by the Agilent Scanner G2505B.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Mass Spectrometric Data Analysis {#sec4.5.1}

We processed the mass spectra using MaxQuant (<http://coxdocs.org/doku.php>) ([@bib16]). Using the Andromeda search engine, the spectra were searched against the mouse Uniprot sequence database (<https://www.uniprot.org>). Cysteine carbamidomethylation was set as fixed modification while variable modifications included hydroxylation of proline and methionine oxidation. For both protein and peptide level we set FDR to 0.01 and only peptides with an amino-acid length of seven or more were considered. The peptide identifications among the library samples from the four brain regions (Cx, OB, SEZ, MEZ) in the LMSS dataset were used to additionally identify peptides in the single shot samples based on similar mass and retention time. The matching between runs feature (a feature of the Max quant software) thus allows identification of proteins in the single shot samples (that were identified in library samples) when precursor peptides were found in MS1, but not selected for fragmentation and identification in MS2. Single shots and library samples were also matched within themselves, which was also the case for samples in the QDSP dataset. The label-free protein quantification was restricted to proteins identified with at least two unique peptides. Label-free quantification (LFQ) algorithm was used for protein quantifications ([@bib15]). LFQ intensities are normalized median mass spectra intensity values that allow this quantification to be performed with any peptide and protein fractionation while maintaining high accuracy ([@bib15]). For a protein to be considered valid, two peptide ratios are needed. Among the QDSP samples, there was one sample with two of the brain regions that had protein fraction with very low protein content and several fractions with lower protein identification. Thus, we omitted the whole sample from further bioinformatics analysis. This resulted in 4 samples per region (each with their respective four solubility fractions).

### Bioinformatic Analysis and Statistics {#sec4.5.2}

Bioinformatic analysis was performed primarily with the Perseus software (coxdocs.org/doku.php) ([@bib96]). For all datasets, we have used log2 LFQ intensities for analysis and comparisons. Plots of selected categories or individual proteins were done in Graphpad Prism (version 5).

### Bioinformatic Analysis of LMSS Dataset {#sec4.5.3}

The presented library proteomes depth signifies number of identified proteins (n = 1/region). The presented library-matched single shot sample measurements are filtered for at least 3 values per region (n = 4/region). This filtering was also used for data imputation. Imputation of missing values was done by random selection according to a normal distribution with negative shift of 1.8 standard deviations from the mean and with a width of 0.3 standard deviations. These log2 LFQ intensities values for all proteins were then used for PCA, statistical analysis, gene ontology analysis and heatmap presentations. Proteome comparisons of regions were done with one-way ANOVA and p values were used for filtering significant regional abundance differences after FDR correction. Heatmaps display proteins with an FDR of 0.05 ([Figure 1](#fig1){ref-type="fig"}K). 1D and 2D enrichment analysis of annotated terms was done in Perseus ([Figures 1](#fig1){ref-type="fig"}L, 1M, [4](#fig4){ref-type="fig"}E, 4F, [1](#fig1){ref-type="fig"}SE, and 1SF) with an FDR of 0.05 and full annotation enrichment lists can be found in [Table S2](#mmc3){ref-type="supplementary-material"}, and 4. Gene ontology analysis for library exclusive proteins was done in Panther ([pantherdb.org](http://pantherdb.org){#intref0175}) ([@bib94]) ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Matrisome distribution plots (Wisker plots) comprise of z-scored mean LFQ intensities for proteins of the respective category (number of proteins for each category is presented in the respective graphs). This data was analyzed using Kruskal-Wallis test with Dunn's multiple comparison test and p ≤ 0.05 was considered significant. For t test comparisons between brain regions an FDR ≤ 0.1 was considered significant.

### Bioinformatic Analysis of QDSP Dataset {#sec4.5.4}

The presented total number of proteins from all regions signifies number of identified proteins (n = 4/region). The total number of identifications from each region is instead filtered for at least 3 values in a region. We filtered the data for at least 8 values in a region prior intensity imputation. Imputation of missing values for the protein fractions of each region was done by random selection according to a normal distribution with negative shift of 1.7 standard deviations from the mean and with a width of 0.4 standard deviations. These log2 LFQ intensities values for all fractions were then used for PCA, annotation enrichment analysis, category solubility profiles, and heatmap presentations. 1D enrichment analysis of annotated terms ([Figures 4](#fig4){ref-type="fig"}E and 4F) used an FDR of 0.05. Category solubility profile plots (Whisker plots) comprise of z-scored mean LFQ intensities for protein fractions of the respective category (number of proteins for each category is presented in the respective graphs). We present the mean value of the three regions in all "brain" solubility profiles for different categories (z-scoring was always done within regions). This data was analyzed using Kruskal-Wallis test with Dunn's multiple comparison test and p ≤ 0.05 was considered significant. Categories in the PCA were considered significant with a FDR ≤ 0.05. Differences between brain region solubility profiles were determined using the z-scored LFQ intensities and two-way ANOVA with FDR correction (p value ≤ 0.05 was considered significant). The matrisome proteins with differential solubility ([Figure 4](#fig4){ref-type="fig"}H) (p value ≤ 0.05) were filtered from the analysis of all proteins (in heatmap, [Figure 4](#fig4){ref-type="fig"}D). In [Figure S5](#mmc1){ref-type="supplementary-material"}C, we compared the brain matrisome data to previously published datasets (using the QDSP method) in aorta and lung tissue ([@bib86], [@bib100]). The averaged solubility profiles here are comprised of an average from all experimental groups of each study.

### Analysis and Presentation of AFM Data {#sec4.5.5}

*Analysis of Raw AFM Data.* First, the force-distance curves collected from AFM measurements were analyzed using a custom-written MATLAB script (described previously in [@bib50] and [@bib51]) to obtain the reduced apparent elastic modulus ***K***, a measure of tissue stiffness. Raw AFM data were fitted to the Hertz model,$$\mathbf{F} = \frac{4}{3}\mathbf{K}\mathbf{\delta}^{\frac{3}{2}}\sqrt{\mathbf{R}}$$

with the applied force **F**, the reduced apparent elastic modulus **K** = *E*/(1*-ν*^2^), with *E* being the Young's modulus and ν the Poisson's ratio, **R** the radius of the probe, and δ the indentation depth ([@bib42]). Force-distance curves were analyzed at the maximum applied force of 10 nN. Points where the AFM data was not analyzable were excluded from further analysis. Criteria for excluding individual force-distance curves were the inability to apply linear fits through the baseline of the curve, e.g., due to noise, and the inability to apply good-quality Hertz-fits to the indentation region. ***K*** values were color-coded and converted to 8-bit scale colormaps, using the MATLAB 'hot' colormap pre-set. The resulting two-dimentional 'stiffness maps' were overlaid onto images of the samples using custom-written MATLAB scripts ([@bib50], [@bib51]). Local brain region stiffness was statistically analyzed using Mann-Whitney test (two-tailed).

### Bioinformatic Analysis Microarray Data {#sec4.5.6}

Agilent Feature Extraction software (version 10.7.3.1) was used to analyze acquired array images. Quantile normalization and subsequent data processing were carried out by Arraystar using the GeneSpring GX v11.5.1 software package (Agilent Technologies). After quantile normalization of the raw data, mRNAs that at least 6 out of 12 samples have flags in Present or Marginal ("All Targets Value") were chosen for further data analysis. Differentially expressed mRNAs were identified through Volcano Plot filtering.

Data and Code Availability {#sec4.6}
--------------------------

The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE ([@bib106]) partner repository and the accession number for the proteomes reported in this paper is ProteomeXchange: [PXD016632](pride:PXD016632){#interref210} (<http://proteomecentral.proteomexchange.org>). We also provide excel tables with the analyzed proteomics data for easy access. Furthermore, the two proteomes are available with pre-made graphs for each protein on the webpage <https://neuronicheproteome.org>. The microarray dataset is accessible at GEO: [GPL15692](ncbi-geo:GPL15692){#intref0195}. Custom-written scripts used for motorised stage control, processing of AFM raw data, and the generation and alignment of colormaps can be found at <https://github.com/FranzeLab>.
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Document S1. Figures S1--S7Table S1. LMSS DatasetThe dataset has been filtered and missing values have been imputed (see STAR Methods). Library-exclusive proteins are provided in a separate sheet. The data are related to Figures 1A--1H and S1A--S1D.Table S2. Annotation Enrichment Analysis LMSS Data1- and 2-dimentional enrichment analysis for the Uniprot "keyword"-annotation performed in Perseus (see STAR Methods). All Niche enrichment analysis has been done with values of each region's protein abundance difference to that of the Cx samples. The data are related to Figures 1L, 1M, S1E, and S1F.Table S3. QDSP DatasetThe dataset has been filtered and missing values have been imputed (see STAR Methods). The data are related to Figures 4, S5A, and S5B.Table S4. Annotation Enrichment Analysis QDSP Data (OB)1-dimentional enrichment analysis for the Uniprot "keyword"-annotation performed in Perseus (see STAR Methods). The data are only analyzed for the proteins in the OB highlighted in Figure 4D and are directly related to Figures 4E and 4F.Table S5. Microarray DatasetThe dataset is based on RNA anlysis of Cx, OB, and SVZ (n = 3 per region). The data are related to Figures 6B and 6C.Table S6. Proteome and Microarray Comparison DatasetThe data display protein that diverge in their expression comparing the proteome and microarray data (significantly higher or lower) and 2-dimentional enrichment analysis for the Uniprot "keyword"-annotation comparing the two data sets. The data are related to Figure 2, S7A, and S7B.Document S2. Article plus Supplemental Information
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